✦ LIBER ✦

The challenge of drug discovery of a GPCR target: Analysis of preclinical pharmacology of histamine H3 antagonists/inverse agonists

✍ Scribed by A.A. Hancock

Book ID: 113487807
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 459 KB
Volume: 71
Category: Article
ISSN: 0006-2952
DOI: 10.1016/j.bcp.2005.10.033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Challenges of drug discovery in novel ta

Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: A novel histamine H4 receptor antagonist

✍ Charles E. Mowbray; Andrew S. Bell; Nicholas P. Clarke; Michelle Collins; Rhys M 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 487 KB

ChemInform Abstract: Challenges of Drug

ChemInform Abstract: Challenges of Drug Discovery in Novel Target Space. The Discovery and Evaluation of PF-3893787 (I): A Novel Histamine H4 Receptor Antagonist.

✍ Charles E. Mowbray; et al. et al. 📂 Article 📅 2012 🏛 John Wiley and Sons ⚖ 19 KB 👁 2 views

Use of an inverse agonist radioligand [3

Use of an inverse agonist radioligand [3H]A-317920 reveals distinct pharmacological profiles of the rat histamine H3 receptor

✍ B. Bei Yao; D.G. Witte; T.R. Miller; T.L. Carr; C.H. Kang; S. Cassar; R. Faghih; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 408 KB

Discovery of potent and selective histam

Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold

✍ H.G.F. Richter; C. Freichel; J. Huwyler; T. Nakagawa; M. Nettekoven; J.-M. Planc 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 453 KB

A novel series of potent histamine H(3) receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold has been discovered. Several compounds display high selectivity over other histamine receptor subtypes and have favorable physicochemical properties, low potential for CY